Search results for IP

Biotin Anti-C3 antibody, Abcam, AB48342

Biotin Anti-CD147 antibody [MEM-M6/1], Abcam, AB21898

ab21898 is a high-affinity antibody capable of binding to unstimulated peripheral blood T cells. The purified antibody is conjugated with Biotin-LC-NHS under optimum conditions. The reagent is free of unconjugated biotin.

Biotin Anti-CD3 epsilon antibody [C363.29B (YCD3-1)], Abcam, AB25688

Biotin Anti-CD43 antibody [MEM-59], Abcam, AB28104

The purified antibody is conjugated with Biotin-LC-NHS under optimum conditions. The reagent is free of unconjugated biotin.

Biotin Anti-CD45.1 antibody [A20], Abcam, AB25011

ab25011 recognizes all mouse leukocytes expressing the CD45.1 allotype. It is useful as a marker for origin of donor and host cells

Biotin Anti-CD69 antibody [H1.2F3], Abcam, AB25008

ab25008 augments PMA-induced T-cell proliferation and induces redirected lysis of Fc receptor-bearing target cells by NK cells.

Biotin Anti-CD9 antibody [A1501], Abcam, AB286172

This product is manufactured by BioVision, an Abcam company and was previously called A1501 Anti-human CD9 biotin conjugated antibody. A1501-50 is the same size as the 50 μg size of ab286172.

Biotin Anti-CGRP antibody, Abcam, AB47856

Biotin Anti-Collagen IV antibody, Abcam, AB6581

At least 11 genetically distinct gene products are collectively referred to as 'collagen types' or other proteins and proteoglycans of the extracellular matrix. In humans, collagens are composed of about 20 unique protein chains which under go various types of post-translational modifications and are ultimately assembled into a triple helix. This results in great diversity between collagen types. Collagens are highly conserved throughout evolution and are characterized by an uninterrupted "Glycine-X-Y" triplet repeat that is a necessary part of the triple helical structure. For these reasons it is often extremely difficult to generate antibodies with specificities to collagens. The development of type specific antibodies is dependent on NON-DENATURED three-dimensional epitopes. This preparation results in a native conformation of the protein. These antibodies are well suited to detect extracellular matrix proteins in normal as well as disease state tissues. Disruption of tissue organization is the hallmark of neoplasia. Malignant lesions can be distinguished from benign by examining the breakdown of basement membranes and loss of 3-dimensional architecture. Malignant cells are presumed to use matrix metalloproteases to degrade barriers created by the extracellular matrix which then allows metastasis to occur. Collagenases, stomelysins and gelatinases can collectively degrade all of the various components of the extracellular matrix, including fibrillar and non-fibrillar collagens and basement membrane glycoproteins.

Biotin Anti-Creatine kinase B type antibody, Abcam, AB48651